股票行情快报：可孚医疗（301087）11月28日主力资金净买入200.86万元

Core Viewpoint - The stock of Kefu Medical (301087) has shown a positive performance with a closing price of 42.5 yuan, reflecting a 1.58% increase on November 28, 2025, amidst varying capital flows from different investor groups [1]. Financial Performance - Kefu Medical reported a total revenue of 2.398 billion yuan for the first three quarters of 2025, marking a year-on-year increase of 6.63% [3]. - The net profit attributable to shareholders for the same period was 260 million yuan, up 3.3% year-on-year [3]. - In Q3 2025, the company achieved a quarterly revenue of 902 million yuan, representing a significant year-on-year growth of 30.72% [3]. - The quarterly net profit for Q3 was approximately 92.83 million yuan, which is a 38.68% increase compared to the previous year [3]. - The company’s gross profit margin stands at 53.35%, which is higher than the industry average of 51.22% [3]. Market Position and Valuation - Kefu Medical has a total market capitalization of 8.878 billion yuan, which is below the industry average of 11.144 billion yuan [3]. - The company’s price-to-earnings (P/E) ratio is 25.59, significantly lower than the industry average of 57.71 [3]. - The price-to-book (P/B) ratio is 1.88, compared to the industry average of 3.89 [3]. - Kefu Medical ranks 24th in net profit and 32nd in P/B ratio within the medical device industry [3]. Investor Sentiment - Over the past 90 days, 8 institutions have rated Kefu Medical, with 7 giving a "buy" rating and 1 an "accumulate" rating [4]. - The average target price set by institutions for the stock is 54.56 yuan [4]. Capital Flow Analysis - On November 28, 2025, the net inflow of main funds was 2.0086 million yuan, accounting for 5.12% of the total transaction amount [1]. - Retail investors showed a net outflow of 167,800 yuan, representing 0.43% of the total transaction amount [1]. - The capital flow data indicates a mixed sentiment among different investor groups, with main funds showing a positive trend while retail and speculative funds experienced outflows [2].